Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. [electronic resource]
Producer: 20120413Description: 1010-20 p. digitalISSN:- 1573-2592
- Animals
- Anisoles -- administration & dosage
- Astrocytes -- drug effects
- Benzamides
- Benzenesulfonates -- administration & dosage
- Cell Differentiation -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Disease Progression
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Female
- Humans
- Imatinib Mesylate
- Macrophages -- drug effects
- Mice
- Mice, Inbred C57BL
- Multiple Sclerosis -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Piperazines -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Pyrimidines -- administration & dosage
- Receptor, Macrophage Colony-Stimulating Factor -- antagonists & inhibitors
- Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors
- Sorafenib
- T-Lymphocytes -- drug effects
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.